Researchers call flexible editorial conduct with the new MASLD nomenclature
Researchers call for more flexible editorial conduct rather than abruptly adopting only the new MASLD nomenclature
The 2023 multi-society Delphi consensus statement suggested renaming NAFLD to metabolic dysfunction-associated steatotic liver disease (MASLD), where “fatty” was replaced by its synonym “steatotic”. While there was consensus among panelists to change the definition by focusing on metabolic dysfunction and omitting the term “nonalcoholic”, only 44% of respondents felt that the term” fatty” was stigmatizing in the first round. These results, and knowledge of how patients and their healthcare providers perceive stigma when referring to NAFLD…